Glazer Capital reports 2.58M KALV shares

KalVista Pharmaceuticals, Inc. Schedule 13G: Glazer Capital, LLC and Paul J. Glazer report beneficial ownership of 2,581,700 shares of Common Stock, representing 4.85% of the class.

Rhea-AI Filing Summary

KalVista Pharmaceuticals, Inc. Schedule 13G: Glazer Capital, LLC and Paul J. Glazer report beneficial ownership of 2,581,700 shares of Common Stock, representing 4.85% of the class. The filing states the Reporting Persons "have ceased to be the beneficial owner of more than five percent of the class of securities."

The statement lists shared voting and dispositive power over the 2,581,700 shares and provides business addresses and CUSIP 483497103. The filing is a routine ownership disclosure under Schedule 13G reporting an ownership position below the 5% threshold.

Insights

Institutional Ownership Analyst

Glazer Capital reports a passive sub-5% stake of 2,581,700 shares (4.85%).

The filing states shared voting and dispositive power over 2,581,700 shares of KalVista Common Stock (CUSIP 483497103), representing 4.85% of the class. It also notes the Reporting Persons have ceased to be beneficial owners above the 5% threshold.

As a Schedule 13G, this indicates a passive reporting position rather than an active investor engagement; subsequent filings would show any change in status or ownership percentage.

Key Figures

Reported shares beneficially owned: 2,581,700 shares Percent of class: 4.85% Shared voting/dispositive power: 2,581,700 shares +2 more

5 metrics

Reported shares beneficially owned 2,581,700 shares Amount beneficially owned reported in Item 4(a)

Percent of class 4.85% Percent of class reported in Item 4(b)

Shared voting/dispositive power 2,581,700 shares Shared voting and shared dispositive power reported in Item 4(c)(ii) and (iv)

CUSIP 483497103 CUSIP listed in Item 2(d)/(e)

Filing date / signature date 06/10/2026 Signature dates on the filing

Key Terms

Schedule 13G, Beneficial ownership, Shared dispositive power

3 terms

Schedule 13G regulatory

"This statement is filed by: Glazer Capital, LLC with respect to the shares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficial ownership regulatory

"Amount beneficially owned: 2,581,700 (b) Percent of class: 4.85%"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Shared dispositive power regulatory

"Shared Dispositive Power 2,581,700.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Glazer Capital hold in KalVista (KALV)?

Glazer Capital and Paul J. Glazer report beneficial ownership of 2,581,700 shares, representing 4.85% of KalVista Common Stock (CUSIP 483497103). The filing is on Schedule 13G.

Does the Schedule 13G show voting or dispositive power for Glazer Capital?

Yes. The filing shows shared voting power and shared dispositive power over 2,581,700 shares of Common Stock, with no sole voting or dispositive power reported.

Has Glazer Capital crossed the 5% ownership threshold for KALV?

The filing states the Reporting Persons "have ceased to be the beneficial owner of more than five percent of the class of securities," indicating the current reported position is below 5% at 4.85%.

What entity and individual filed the Schedule 13G for KALV?

The Schedule 13G is filed by Glazer Capital, LLC (a Delaware limited liability company) and Paul J. Glazer, the Managing Member, with a business address in New York.

Which CUSIP and class of security are reported in this filing?

The filing covers KalVista Common Stock, $0.001 par value per share, with CUSIP 483497103, as identified in Item 2(d) of the statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 05:03 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

KalVista Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

483497103

(CUSIP Number)

06/03/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 483497103

1

Names of Reporting Persons

Glazer Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,581,700.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,581,700.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,581,700.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.85 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP Number(s): 483497103

1

Names of Reporting Persons

Paul J. Glazer

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,581,700.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,581,700.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,581,700.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.85 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KalVista Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: 200 Crossing Boulevard, Framingham, Massachusetts 01702
Item 2.
(a)	Name of person filing: This statement is filed by: (i) Glazer Capital, LLC, a Delaware limited liability company ("Glazer Capital"), with respect to the shares of Common Stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Glazer Capital serves as investment manager (collectively, the "Glazer Funds"); and (ii) Mr. Paul J. Glazer ("Mr. Glazer"), who serves as the Managing Member of Glazer Capital, with respect to the shares of Common Stock held by the Glazer Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock (as defined in Item 2(d)) reported herein.
(b)	Address or principal business office or, if none, residence: The address of the business office of each of the Reporting Persons is 250 West 55th Street, Suite 30A, New York, New York 10019.
(c)	Citizenship: Glazer Capital is a Delaware limited liability company. Mr. Glazer is a United States citizen.
(d)	Title of class of securities: Common Stock, $0.001 par value per share
(e)	CUSIP Number(s): 483497103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,581,700
(b)	Percent of class: 4.85%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2,581,700
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2,581,700
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Reporting Persons may have been deemed to beneficially own more than 5% of the outstanding shares on the date of event that required the filing of the Schedule 13G. As of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Glazer Capital, LLC

Signature:	Paul J. Glazer
Name/Title:	Paul J. Glazer, Managing Member
Date:	06/10/2026

Paul J. Glazer

Signature:	Paul J. Glazer
Name/Title:	Paul J. Glazer
Date:	06/10/2026